跳至主要内容
临床试验/KCT0001054
KCT0001054尚未招募未知

Development for an immortalized standard cell lines of disease genetics

Inje University Busan Paik Hospital0 个研究点目标入组 250 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. The person received written consent to participate in research after full description of the building database of reference material on genetic analysis
  • 2. The person who agreed written consent to participate in research after understanding the possibility of application of their blood or its derivatives as standard materials in genetic tests
  • 3. Healthy adults over the age of 19
  • 4. Those without a history of leukemia
  • 5. Person who does not have a foreigner in kinship

排除标准

  • 1. Minors under the age of 19
  • 2. Person who have a foreigner in kinship
  • 3. Person Who have a history of leukemia

研究者

相似试验

招募中
不适用
Establishment of immortalized cells involved in endometriosis and ovarian tumor.endometriosis, ovarian cyst
JPRN-UMIN000030867agoya University40
进行中(未招募)
1 期
stem cell transplantation in pancreatic cancer after surgical resectioMedDRA version: 17.0 Level: LLT Classification code 10033604 Term: Pancreatic cancer System Organ Class: 100000004864pancreatic cancer
EUCTR2012-003528-19-DERuprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial12
进行中(未招募)
不适用
AN OPEN LABEL PHASE III STUDY OF A VERO CELL-DERIVED WHOLE VIRUS H5N1 INFLUENZA VACCINE TO ASSESS THE IMMUNOGENICITY AND SAFETY AND TO INVESTIGATE THE NEED FOR AND TIMING OF A BOOSTER VACCINATION - Phase 3 H5N1 Influenza Vaccine StudyH5N1 Influenza vaccination in healthy subjectsMedDRA version: 9.1Level: LLTClassification code 10022000Term: Influenza
EUCTR2006-006307-37-DEBaxter Innovations GmbH550
进行中(未招募)
不适用
AN OPEN LABEL PHASE III STUDY OF A VERO CELL-DERIVED WHOLE VIRUS H5N1 INFLUENZA VACCINE TO ASSESS THE IMMUNOGENICITY AND SAFETY AND TO INVESTIGATE THE NEED FOR AND TIMING OF A BOOSTER VACCINATION - Phase 3 H5N1 Influenza Vaccine StudyH5N1 Influenza vaccination in healthy subjectsMedDRA version: 9.1Level: LLTClassification code 10022000Term: Influenza
EUCTR2006-006307-37-ATBaxter Innovations GmbH550
招募中
Unknown
Development of fibroblast sheets aiming for the practical applicatio
JPRN-UMIN000049999Yamaguchi University10